Knockdown of FTO made melanoma cells more sensitive to interferon gamma (IFN-γ), thereby reducing the resistance to anti-PD-1 therapy in mice in an adaptive immunity-dependent manner (129, 137). The gene discussed is IFNG; the disease is melanoma.